148 related articles for article (PubMed ID: 34657337)
1. Efficacy of dupilumab in eosinophilic dermatosis of haematologic malignancy (EDHM) needs to be confirmed.
Sibaud V; Brun A; Meyer N; Oberic L; Lamant L; Ysebaert L
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e213-e215. PubMed ID: 34657337
[No Abstract] [Full Text] [Related]
2. Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy.
Maglie R; Ugolini F; De Logu F; Simi S; Senatore S; Montefusco F; Nassini R; Massi D; Antiga E
J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e501-e503. PubMed ID: 33730368
[No Abstract] [Full Text] [Related]
3. Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia.
Jin A; Pousti BT; Savage KT; Mollanazar NK; Lee JB; Hsu S
JAAD Case Rep; 2019 Sep; 5(9):815-817. PubMed ID: 31508473
[No Abstract] [Full Text] [Related]
4. What's in a name? a new nomenclature has been proposed For eosinophilic dermatosis of hematologic malignancy (EDHM): hematologic-related malignancy-induced eosinophilic dermatosis (He Remained).
Cohen PR
Dermatol Online J; 2020 Jun; 26(6):. PubMed ID: 32815699
[TBL] [Abstract][Full Text] [Related]
5. Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease?
Qiao J; Sun CE; Zhu W; Zhu D; Fang H
Int J Clin Exp Pathol; 2013; 6(8):1683-7. PubMed ID: 23923089
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilic dermatosis of hematologic malignancy.
Martires K; Callahan S; Terushkin V; Brinster N; Leger M; Soter NA
Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329554
[TBL] [Abstract][Full Text] [Related]
7. Targeted inhibition of IL-4/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy.
Goyal A; Lofgreen S; Mariash E; Bershow A; Gaddis KJ
Dermatol Ther; 2020 Jul; 33(4):e13725. PubMed ID: 32558294
[No Abstract] [Full Text] [Related]
8. Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia.
Cohen PR
J Am Acad Dermatol; 2020 Jan; 82(1):e13-e14. PubMed ID: 31473296
[No Abstract] [Full Text] [Related]
9. Response to: "Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia".
Maglie R; Grandi V; Antiga E
J Am Acad Dermatol; 2020 Jan; 82(1):e15-e16. PubMed ID: 31473299
[No Abstract] [Full Text] [Related]
10. Eosinophilic folliculitis, eosinophilic dermatosis of hematologic malignancy and acneiform follicular mucinosis: Two case reports and a review of the literature highlighting the spectrum of histopathology.
Bailey CAR; Laurain DA; Sheinbein DM; Jones HA; Compton LA; Rosman IS
J Cutan Pathol; 2021 Mar; 48(3):439-450. PubMed ID: 33617128
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilic dermatosis of haematological malignancy.
Jayasekera PS; Bakshi A; Al-Sharqi A
Clin Exp Dermatol; 2016 Aug; 41(6):692-5. PubMed ID: 27378400
[No Abstract] [Full Text] [Related]
12. Eosinophilic dermatosis of hematologic malignancy.
Farber MJ; La Forgia S; Sahu J; Lee JB
J Cutan Pathol; 2012 Jul; 39(7):690-5. PubMed ID: 22612903
[TBL] [Abstract][Full Text] [Related]
13. Eosinophilic dermatosis of hematologic malignancy effectively controlled with omalizumab maintenance therapy.
Lor M; Gates G; Yu Y
Dermatol Ther; 2020 Nov; 33(6):e14206. PubMed ID: 32816408
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy.
Maglie R; Ugolini F; De Logu F; Nassini R; Simi S; Nardiello P; Pasqualini E; Baroni G; Del Bianco E; Massi D; Antiga E
J Am Acad Dermatol; 2022 Oct; 87(4):761-770. PubMed ID: 34265409
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic Dermatosis of Hematologic Malignancy: Emerging Evidence for the Role of Insect Bites-A Retrospective Clinico-Pathological Study of 35 Cases.
Michelerio A; Rubatto M; Roccuzzo G; Coscia M; Quaglino P; Tomasini C
J Clin Med; 2024 May; 13(10):. PubMed ID: 38792476
[No Abstract] [Full Text] [Related]
16. Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin's B lymphoma: a single center prospective clinico-pathological study.
Michelerio A; Tomasini C; Fiandrino G; De Amici M; Varettoni M; Defrancesco I; Cavalloni C; Brazzelli V; Derlino F; Paulli M; Arcaini L; Vassallo C
Front Med (Lausanne); 2023; 10():1231003. PubMed ID: 37614953
[TBL] [Abstract][Full Text] [Related]
17. Eosinophilic dermatosis in a patient with chronic lymphocytic leukemia: a rare case report.
Gardikioti A; Venou TM; Mainou M; Nikolaidou C; Klonizakis P; Vetsiou E; Psarras K; Vlachaki E
Acta Dermatovenerol Alp Pannonica Adriat; 2021 Dec; 30(4):161-164. PubMed ID: 34929993
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic dermatosis of hematologic malignancy: Correlation of molecular characteristics of skin lesions and extracutaneous manifestations of hematologic malignancy.
Meiss F; Technau-Hafsi K; Kern JS; May AM
J Cutan Pathol; 2019 Mar; 46(3):175-181. PubMed ID: 30411384
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic dermatosis of hematologic malignancy: a case report.
Almeida FT; Caldas R; Rodrigues AP; Ferreira O; Brito C
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609451
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the management of eosinophilic dermatosis of hematological malignancy.
Tan S; Choong DJ; Tan E
Int J Dermatol; 2024 May; ():. PubMed ID: 38727148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
